Anti-proliferative effects and induction of apoptosis by liquiritigenin in human hepatocellular carcinoma SMMC-7721 cells

Journal of Traditional Medicines

Volumn 25, Issue 42496, 2008, Pages 160-165

  Higo, Haruo ^a   Zhang, Shi Ping ^a   He, Ling ^b   Li, Fu ^b   Liu, Yan ^a   Cai, Yun Qing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

apoptosis; bcl 2; flavonoid; liquiritigenin; p53; SMMC 7721 cell

Indexed keywords

EID: 85024451343     PISSN: 18801447     EISSN: 18813747     Source Type: Journal    
DOI: 10.11339/jtm.25.160     Document Type: Article

References (28)

1. Seow, T.K., Liang, R.C., Leow, C.K., and Chung, M.C.: Hepatocelula carcinoma. from bedside to proteomics. Proteomics 1 (10), 1249-1263, 2001.
2. Kern, M.A., Breuhahn, K., and Schirmacher, P.: Molecular pathogenesis of human hepatocellular carcinoma. Adv Cancer Res 86, 67-112, 2002.
3. Bruix, J., Boix, L., Sala, M., and Llovet, JM.: Focus on hepatocellular carcinoma. Cancer Cell 5 (3), 215-219, 2004.
4. Deng, Xu-Kun., Yin, Wu., and Li, Wei-Dong.: The anti-tumor effects of alkaloids from the seeds of Strychnos nux-vomica on HepG2 cells and its possible mechanism. Journal of Ethnopharmacology 106, 179-186, 2006.
5. Chang, J.S., Hsu, Y.L., Kuo, P.L., Kuo, Y.C., Chiang, L.C., and Lin, C.C.: Increase of Bax/Bcl-XL ratio and arrest of cell cycle by luteolin in immortalized human hepatoma cell line. Life Sciences 76, 1883-1893, 2005.
6. Ren, W., Qiao, Z., Wang, H., Zhu, L., and Zhang, L.: Flavonoids: promising anticancer agents. Med Res Rev 23 (4), 519-534, 2003.
7. Matsuzaki, Y., Kurokawa, N., Terai, S., Matsumura, Y., Kobayashi, N., and Okita, K.: Cell death induced by baicalein in human hepatocellular carcinoma cell lines. Jpn J Cancer Res 87 (2), 170-177, 1996.
8. Okita, K., Li, Q., Murakamio, T. and Takahashi, M.: Anti-growth effects with components of Sho-saiko-to (TJ-9) on cultured human hepatoma cells. Eur J Cancer Prey 2 (2), 169-175, 1993.
9. Motoo, Y., Sawabu, N.: Antitumor effects of saikosaponins, baicalin and baicalein on human hepatoma cell lines. Cancer Lett 86 (1), 91-95, 1994.
10. Fiala, E.S., Reddy, B.S., and Weisburger, J. H.: Naturally occurring anticarcinogenicsubstances in foodstuffs. Ann. Rev. Nutr 5, 295-321, 1985.
11. Chen, J.W., Zhu, Z.Q., Hu, T.X., and Zhu, D.Y.: Structure-activity relationship of natural flavonoids in hydroxyl radical-scavenging effects. Acta Pharmacol Sin 23, 667-672, 2002.
12. Wenzel, U., Kuntz, S., Brendel, MD., and Daniel, H.: Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res 60, 3823-3831, 2000.
13. Pan, MH., Chen, WJ., Lin-Shinau, SY., Ho, CT., and Lin, JK.: Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. Carcinogenesis 23, 1677-1684, 2002.
14. Hirano, T., Abe, K., Gotoh, M., and Oka, K.: Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. Br J Cancer 72, 1380-1388, 1995.
15. Ohtake, N., Suzuki, R., and Daikuhara, H.: Modulation of lung local immune responses by oral administration of a herbal medicine Sho-saiko-to. Int J Immunopharmacol 22 (6), 419-430, 2000.
16. Yamashiki, M., Nishimura, A., Nomoto, M., Suzuki, H., Kosaka, Y.: Herbal medicine ‘Sho-saiko-tO' induces tumour necrosis factor-alpha and granulocyte colony-stimulating factor in vitro in peripheral blood mononuclear cells of patients with hepatocellular carcinoma. J Gastroenterol Hepatol 11 (2), 137-142, 1996.
17. Ockshin, R.A.: Programmed cell death: history and future of a concept. Journal de la Société de biologie 199 (3), 169-173, 2005.
18. Birt, D.F., Hendrich, S., and Wang, W.: Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol. Ther 90 (2-3), 157-177, 2001.
19. Evan, GI., and Vousden, KH.: Proliferation, cell cycle and apoptosis in cancer. Nature 411 (6835), 342-348, 2001.
20. Hengartner, M.O.: The biochemistry of apoptosis. Nature 407, 770-776, 2000.
21. Brown, J.M., and Wouters, B.G.: Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res 59, 1391-1399, 1999.
22. Pirollo, KF., Bouker, KB., and Chang, EH.: Does p53 status influence tumor response to anticancer therapies? Anticancer Drugs 11 (6), 419-432, 2000.
23. Kaul, R., Mukherjee, S., Ahmed, F., Bhat, MK., Chhipa, R., Galande, S., and Chattopadhyay, S.: Direct interaction with and activation of p53 by SMAR1 retards cell-cycle progression at G2/M phase and delays tumor growth in mice. Int J Cancer 103 (5), 606-615, 2003.
24. Nylander, K., Dabelsteen, E., and Hall, PA.: The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med 29 (9), 413-425, 2000.
25. Korsmeyer, SJ.: Regulators of cell death. Trends Genet 11 (3), 101-105, 1995.
26. Reed, J.C.: Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Currrent Opinion in Oncology 7, 541-546, 1995.
27. Alnemri, E., Livingston, D., Salvesen, G., Thormberry, N., Wong, W., and Yuan, J.: Human ICE/CED-3 protease nomenclature. Cell 87, 5437-5433, 1996.
28. Thornberry, NA.: Caspases: a decade of death research. Cell Death Differ 6 (11), 1023-1027, 1999.